Global Pharma and Biotech Dealmaking Royalty Rate Trends Report 2021: Analysis of Licensed, Royalty Rates, License Fees, Upfront and Milestone Payments
26 janv. 2022 06h28 HE
|
Research and Markets
Dublin, Jan. 26, 2022 (GLOBE NEWSWIRE) -- The "Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2021" report has been added to ResearchAndMarkets.com's offering. The Global Royalty...
Sugarmade Signs Binding LOI to Enter Rare Cannabinoid Market via License Agreement for Patented THC-V Rich Chemovars
24 janv. 2022 08h30 HE
|
Sugarmade, Inc.
NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Sugarmade, Inc. (OTC Pink: SGMD) ("Sugarmade", "SGMD" or the "Company") an emerging leader in the licensed cannabis sector, is pleased...
Insights on the Aseptic Pharma Processing Global Market to 2031 - Emergence of Data within the Aseptic Processing Industry Presents Opportunities
24 janv. 2022 06h28 HE
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Aseptic Pharma Processing Market - Global and Regional Analysis: Focus on Product, Technology, Regional and Country Analysis - Analysis and Forecast,...
Occupational Health Market Size, $5,493.39 Million by 2028 Lead by Hearing Loss Due to Noise Segment, 3.2% CAGR - Exclusive Research Report by The Insight Partners
24 janv. 2022 06h17 HE
|
The Insight Partners
New York, Jan. 24, 2022 (GLOBE NEWSWIRE) -- According to our new research study on “Occupational Health Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type (Work Induced Stress,...
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
20 janv. 2022 16h30 HE
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
IBN (InvestorBrandNetwork) Announces EDGE Podcast Interview with Lexaria Bioscience Corp. CEO Chris Bunka
20 janv. 2022 08h00 HE
|
InvestorBrandNetwork (IBN)
NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- IBN (InvestorBrandNetwork), a multifaceted financial news and publishing company for private and public entities, today announces that...
AGC Biologics Names Regina Choi-Rivera New General Manager of Boulder, Colorado Mammalian Production Facility
18 janv. 2022 09h05 HE
|
AGC Biologics
Boulder, Colo., Jan. 18, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced Regina Choi-Rivera as...
Clarus Therapeutics Appoints Dr. Zhanna Jumadilova as Chief Clinical Development Officer
18 janv. 2022 09h05 HE
|
Clarus Therapeutics Holdings, Inc.
Dr. Jumadilova most recently led clinical development programs at Insmed and Pfizer and has nearly 30 years of combined pharmaceutical and biotech experience NORTHBROOK, Ill., Jan. 18, 2022 (GLOBE...
Sanofi: Informations relatives au nombre de droits de vote et d'actions – Décembre 2021
17 janv. 2022 13h14 HE
|
Sanofi - Aventis Groupe
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés...
Sanofi: Information concerning the total number of voting rights and shares – December 2021
17 janv. 2022 13h14 HE
|
Sanofi - Aventis Groupe
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...